Author

Eric Hoffmeyer

University of Colorado Anschutz

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Assay:CITE-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Dallas Jones· 2 shared Elena WoodsiD· 2 shared Joaquin Maximiliano EspinosaiD· 2 shared Michael R. VernerisiD· 2 shared Anagha Inguva· 1 shared Angela L. RachubinskiiD· 1 shared Angelo D’AlessandroiD· 1 shared Bartosz J. GrzywacziD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Dallas Jones

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Metabolic vulnerabilities in Down syndrome B-cell acute lymphoblastic leukemia can be targeted using Venetoclax

Dallas Jones, Elena Woods, Zhenhua Li, Kristin L. Schaller, Eric Hoffmeyer, Ben Kooiman, Joseph Fernandez, Tegan Wharton, Dejene Tufa, Spencer C. Hall, George Trahan, Kelly W. Maloney, Holly Pacenta, Kelly Sullivan, Joaquin Espinosa, , Michael R. Verneris

This study identifies metabolic vulnerabilities in Down syndrome B-cell acute lymphoblastic leukemia and shows that Venetoclax effectively targets these vulnerabilities.

Haematologica · Oct 22, 2026Peer-reviewedCancer Biology

Progressive deterioration of adaptive immune repertoires in Down syndrome linked to interferon hyperactivity and lymphoid tissue disorganization

Micah G. Donovan, Neetha Paul Eduthan, Brian F. Niemeyer, Elena Woods, Eric Hoffmeyer, Natália Jaeger, Eleanor C. Britton, Bartosz J. Grzywacz, Joseph J. Fernandez, Galileo S. Dumont, Brian William Herrmann, Norman R. Friedman, Dallas Jones, Zdeněk Andrysík, Angela L. Rachubinski, , Joaquin Maximiliano Espinosa

This study identifies hyperactive interferon signaling and lymphoid tissue disorganization as drivers of adaptive immune dysfunction in Down syndrome across development and aging.

bioRxiv · Aug 4, 2026 · PreprintImmunology